4015.SR
Jamjoom Pharmaceuticals Factory Company
Healthcare · Drug Manufacturers - Specialty & Generic
✓ ETHICAL PASS

MODERATE MOAT
MODERATE
Data Confidence: 57%
Some financial metrics pending
Market Cap
$2.9B
Trailing P/E
24.04
Forward P/E
Rev Growth
+5.2%
Profit Margin
31.2%
ROE
29.0%
Analyst Target
$164.24
Recommendation
NONE
About Jamjoom Pharmaceuticals Factory Company

Jamjoom Pharmaceuticals Factory Company, together with its subsidiaries, engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally. It provides human medicines; nutraceuticals; antibiotics; general analgesics; medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, and ulcer and acidity; treatment of various skin infections and cancer diseases; and eye drops, and ointments and cosmeceuticals.

Ethical Screen
Business Activity
Debt Ratio
Cash Ratio
Receivables Ratio
Revenue Ratio
OverallPASS
Score Valuation: 33.0
Score Quality: 43.8
Score Combined: 32.9
Fair Value Est: $25.50

Full Analysis

Opportunity scores, earnings history, insider transactions, institutional holders, analyst consensus, and more.

Unlock with Membership
Opportunity Scores
Valuation60.1
Quality50.2
Cash Flow50.0
Moat50.0
Balance Sheet50.0
Debt Purity50.0
Liquid Purity50.0
Rev Purity50.0
Compliance100.0
Tier: BRONZE · Score: 47.4 · Rank: #2515
Insider Transactions
No insider transaction data.
Top Institutional Holders
No institutional holder data.
Additional Fundamentals
Enterprise Value
$10.6B
Price/Book
6.21
Beta
0.326
Analysts
3
Total Revenue (TTM)
$1.5B
Total Debt
$20.8M
Earnings Growth
+7.1%
Dividend Yield
2.6%
Quantitative Grade

A single score combining all analytical layers below. A is strongest, D is weakest.

C
Quant Score
46.7
Risk Grade
LOW_RISK
Layers
7
Risk Profile

How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.

VaR 95%
-2.8%
worst expected daily loss, 19 in 20 days
CVaR 95%
-3.9%
avg loss on the worst 5% of days
Annual Volatility
Sortino Ratio
0.60
above 1.0 is good
Max Drawdown
-35.4%
Worst Day
Forward Outlook

Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.

30d Prob Up
90d Prob Up
Median Return 30d
Liquidity Score
52
Liquidity Grade
MODERATE
Trend & Momentum

What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?

Kalman Trend
Trend Strength
Momentum Signal
HMM Regime
RSI Signal
Technical Signals

Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.

MA Crossover
GOLDEN_CROSS
Bollinger Position
LOWER_HALF
Beta
Relative Volume
1.3x
Short Interest
Financial Health

Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.

Altman Z-Score
below 1.81 = distress zone
Piotroski F-Score
Earnings Beat Rate
Earnings Consistency
Correlations

These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.

Most Correlated
TickerCorrelation
4016.SR0.412
4084.SR0.380
4006.SR0.353
2081.SR0.347
4031.SR0.338
Inverse Correlated
TickerCorrelation
GLIBA-0.181
CRI-0.154
GLIBK-0.153
LUCK.KA-0.135
VTMX-0.132
Seasonality

Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.

Best Day
Wednesday
Worst Day
Thursday
Best Month
Apr
Worst Month
Oct
Fri-Mon Effect
-0.11220275645732324
Momentum Rankings

How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.

1M Return
-1.2%
3M Return
+21.6%
6M Return
+7.3%
12M Return
-8.1%
Momentum Rank
#1825
Momentum Signal
UP

Get our daily market read free. Join thousands of traders.

Free Explorer Access